GT Biopharma, Inc. (GTBP)
0.45
-0.02
(-4.26%)
USD |
NASDAQ |
Mar 06, 16:00
0.45
0.00 (0.00%)
After-Hours: 20:00
GT Biopharma Free Cash Flow : -12.91M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Lyell Immunopharma, Inc. | -165.54M |
| Regeneron Pharmaceuticals, Inc. | 3.765B |
| SELLAS Life Sciences Group, Inc. | -30.62M |
| Crinetics Pharmaceuticals, Inc. | -383.68M |
| Sutro Biopharma, Inc. | -225.11M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -4.021M |
| Cash from Financing (Quarterly) | 8.305M |
| Free Cash Flow Per Share (Quarterly) | -0.6141 |
| Free Cash Flow to Equity (Quarterly) | -4.021M |
| Free Cash Flow to Firm (Quarterly) | -3.894M |
| Free Cash Flow Yield | -735.6% |